Market research
MBX.TO Microbix Biosystems Inc
TO CAD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 0.4
- Dividend yield
- Not available
- Beta
- 0.54
Profile
Instrument facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- CA59501P1045
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 0.4
- Dividend yield
- Not available
- Beta
- 0.54
About
About Microbix Biosystems Inc
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Research context
Microbix Biosystems Inc appears in PyInvesting’s Toronto Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the MBX.TO discussion.
5 years, 6 months ago
Microbix Biosystems Inc is currently in a long term uptrend where the price is trading 8.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.2.
Microbix Biosystems Inc's total revenue rose by 54.3% to $3M since the same quarter in the previous year.
Its net income has increased by 122.4% to $131K since the same quarter in the previous year.
Finally, its free cash flow fell by 532.5% to $-462K since the same quarter in the previous year.
Based on the above factors, Microbix Biosystems Inc gets an overall score of 4/5.